Sage Journals: Discover world-class research

Retricted access

Review article

First published 2018-6

Is there an overlooked “window of opportunity” in MS exercise therapy? Perspectives for early MS rehabilitation

Morten Riemenschneider, Lars G Hvid, Egon Stenager [...]

Multiple Sclerosis Journal

Retricted access

Case report

First published 2016-2

MS arising during Tocilizumab therapy for rheumatoid arthritis

Philippe Beauchemin, Robert Carruthers

Multiple Sclerosis Journal

Retricted access

Review article

First published 2015-9

The re-emergence of antigen-specific tolerance as a potential therapy for MS

Lawrence Steinman

Multiple Sclerosis Journal

Open access

Research article

First published 2024-1

Effectiveness of a blended booster programme for the long-term outcome of cognitive behavioural therapy for MS-related fatigue: A randomized controlled trial

Marieke de Gier, Heleen Beckerman, Jos WR Twisk [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2006-12-4

Utilization of rehabilitation therapies by nursing home residents with MS at admission

Robert J. Buchanan, Suojin Wang, Raymond A. Martin [...]

NeuroRehabilitation

Retricted access

Research article

First published 2015-2

Signaling networks in MS: A systems-based approach to developing new pharmacological therapies

Ekaterina Kotelnikova, Marti Bernardo-Faura, Gilad Silberberg [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2018-1

MS People’s Performance and Satisfaction With Daily Occupations: Implications for Occupational Therapy

Eman J. Abdullah, Hanan E. Badr, Fahad Manee

OTJR: Occupational Therapy Journal of Research

Retricted access

Research article

First published 2025-2

DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trial

John R Corboy, Robert J Fox, Gary Cutter [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2018-12

Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MS

Elizabeth A Mills, Joel A Begay, Caitlyn Fisher [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2018-7

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

Fredrik Piehl, Ingrid Kockum, Mohsen Khademi [...]

Multiple Sclerosis Journal

Search results